Anti-Obesity Medications: Mechanisms of Action, Lifestyle Implications, and Future Developments


The past 20 years have brought an exponential increase in our knowledge about the pathophysiology of metabolic disease states, including obesity. We now understand why lifestyle alone is not sufficient for many people to manage these disease states. With knowledge comes new treatment options, including new medications that are bringing life saving help and quality of life improvement to thousands of people living with obesity. In this session we will provide an overview of currently approved anti-obesity medications (AOMs), the medications in the pipeline, mechanisms of action and dietary and lifestyle implications to complement AOMs and mitigate common side effects.

Planned with the Committee for Lifelong Learning

Learning Objectives

Define the pathophysiology of obesity in order to identify appropriate treatment paths

Describe the mechanisms of action of medications approved to treat obesity in order to effectively deliver nutrition and lifestyle interventions

Explain the role of nutrition and lifestyle interventions as a complement to medication and to mitigate common side effects.


Amanda Velazquez

Director of Obesity Medicine, Assistant Professor of Medicine and Surgery

Cedars-Sinai Medical Center

Amy von Sydow Green

Clinical Dietitian

PENN Metabolic Medicine


Julie Schwartz

Obesity Medicine Registered Dietitian Nutritionist Case Manager

Intellihealth Inc.

Scroll to Top